ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR MYELOFIBROSIS - CLOSE POST-TRANSPLANT SURVEILLANCE IS MANDATORY

被引：0
|
作者：
Baurmann, H. [1 ]
Thiede, C. [2 ]
Burlakova, I [1 ]
Judith, D. [1 ]
Heshmat, M. [1 ]
Schleuning, M. [1 ]
Schwerdtfeger, R. [1 ]
机构：
[1] German Clin Diagnost, Wiesbaden, Germany
[2] Univ Hosp Carl Gustav Carus, Dresden, Germany
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2010年 / 16卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2009.12.398
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
354
引用
收藏
页码：S289 / S289
页数：1
相关论文
共 50 条
  • [41] Time from autologous to allogeneic hematopoietic stem cell transplantation impacts post-transplant outcomes in multiple myeloma
    Fiorenza, Salvatore
    Routledge, David
    Collins, Jenny
    Shipton, Michael
    Harrison, Simon
    Bajel, Ashish
    Cavet, James
    Tholouli, Eleni
    Gauthier, Jordan
    Ritchie, David
    BONE MARROW TRANSPLANTATION, 2020, 55 (06) : 1172 - 1174
  • [42] Allogeneic hematopoietic cell transplantation in myelofibrosis with myeloid metaplasia
    Hogan W.J.
    Litzow M.R.
    Tefferi A.
    Current Hematologic Malignancy Reports, 2007, 2 (1) : 34 - 42
  • [43] Clinicopathologic spectrum and EBV status of post-transplant lymphoproliferative disorders after allogeneic hematopoietic stem cell transplantation
    Ding-Bao Chen
    Qiu-Jing Song
    Yun-Xin Chen
    Yu-Hong Chen
    Dan-Hua Shen
    International Journal of Hematology, 2013, 97 : 117 - 124
  • [44] Time from autologous to allogeneic hematopoietic stem cell transplantation impacts post-transplant outcomes in multiple myeloma
    Salvatore Fiorenza
    David Routledge
    Jenny Collins
    Michael Shipton
    Simon Harrison
    Ashish Bajel
    James Cavet
    Eleni Tholouli
    Jordan Gauthier
    David Ritchie
    Bone Marrow Transplantation, 2020, 55 : 1172 - 1174
  • [45] Post-Transplant Cyclophosphamide Equalizes Clinical Outcomes of Allogeneic Hematopoietic Cell Transplantation across Racial and Ethnic Populations
    Caprice, Teresa
    Fan, Wenyi
    Kim, Jongphil
    Faramand, Rawan
    Mishra, Asmita
    Perez, Lia
    Khimani, Farhad
    Lazaryan, Aleksandr
    Ochoa-Bayona, Jose L.
    Liu, Hien
    Jain, Michael D.
    Nieder, Michael
    Anasetti, Claudio
    Nishihori, Taiga
    Pidala, Joseph A.
    Bejanyan, Nelli
    Elmariah, Hany
    BLOOD, 2023, 142
  • [46] EBV-associated post-transplant lymphoproliferative disorder after pediatric allogeneic hematopoietic stem cell transplantation
    Yoo, Keen Hee
    Kim, Hee-Jin
    Ki, Chang Seok
    Sung, Ki Woong
    Jung, Hye Lim
    Ko, Youn Hyeh
    Koo, Hong-Hoe
    BLOOD, 2007, 110 (11) : 322B - 322B
  • [47] Clinicopathologic spectrum and EBV status of post-transplant lymphoproliferative disorders after allogeneic hematopoietic stem cell transplantation
    Chen, Ding-Bao
    Song, Qiu-Jing
    Chen, Yun-Xin
    Chen, Yu-Hong
    Shen, Dan-Hua
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 97 (01) : 117 - 124
  • [48] Post-Transplant Lymphoproliferative Disease (PTLD) after Allogeneic Hematopoietic Stem Cell Transplantation: Biology and Treatment Options
    Clerico, Michele
    Dogliotti, Irene
    Aroldi, Andrea
    Consoli, Chiara
    Giaccone, Luisa
    Bruno, Benedetto
    Cavallo, Federica
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (24)
  • [49] Primary central nervous system post-transplant lymphoproliferative disorders following allogeneic hematopoietic stem cell transplantation
    Lieberman, Frank
    Yazbeck, Victor
    Raptis, Anastasios
    Felgar, Raymond
    Boyiadzis, Michael
    JOURNAL OF NEURO-ONCOLOGY, 2012, 107 (02) : 225 - 232
  • [50] Cytokine induced killer (CIK) cells as post-transplant immunotherapy following allogeneic hematopoietic cell transplantation.
    Laport, Ginna G.
    Sheehan, Kevin
    Lowsky, Robert
    Shizuru, Judith A.
    Stockerl-Goldstein, Keith
    Johnston, Laura J.
    Miklos, David
    Arai, Sally
    Baker, Jeanette
    Negrin, Robert S.
    BLOOD, 2006, 108 (11) : 126A - 126A
12345